Anti-GUC2B/ GUCA2B/ GCAP-II functional antibody
Anti-GUC2B/ GUCA2B/ GCAP-II functional antibody for cell culture, ELISA & in-vivo assay
Go to GUCA2B/GUCA2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0250-Ab-1/ GM-Tg-hg-SE0250-Ab-2 | Anti-Human GUCA2B monoclonal antibody | Human |
GM-Tg-rg-SE0250-Ab-1/ GM-Tg-rg-SE0250-Ab-2 | Anti-Rat GUCA2B monoclonal antibody | Rat |
GM-Tg-mg-SE0250-Ab-1/ GM-Tg-mg-SE0250-Ab-2 | Anti-Mouse GUCA2B monoclonal antibody | Mouse |
GM-Tg-cynog-SE0250-Ab-1/ GM-Tg-cynog-SE0250-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GUCA2B monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0250-Ab-1/ GM-Tg-felg-SE0250-Ab-2 | Anti-Feline GUCA2B monoclonal antibody | Feline |
GM-Tg-cang-SE0250-Ab-1/ GM-Tg-cang-SE0250-Ab-2 | Anti-Canine GUCA2B monoclonal antibody | Canine |
GM-Tg-bovg-SE0250-Ab-1/ GM-Tg-bovg-SE0250-Ab-2 | Anti-Bovine GUCA2B monoclonal antibody | Bovine |
GM-Tg-equg-SE0250-Ab-1/ GM-Tg-equg-SE0250-Ab-2 | Anti-Equine GUCA2B monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0250-Ab-1/ GM-Tg-hg-SE0250-Ab-2; GM-Tg-rg-SE0250-Ab-1/ GM-Tg-rg-SE0250-Ab-2; GM-Tg-mg-SE0250-Ab-1/ GM-Tg-mg-SE0250-Ab-2; GM-Tg-cynog-SE0250-Ab-1/ GM-Tg-cynog-SE0250-Ab-2; GM-Tg-felg-SE0250-Ab-1/ GM-Tg-felg-SE0250-Ab-2; GM-Tg-cang-SE0250-Ab-1/ GM-Tg-cang-SE0250-Ab-2; GM-Tg-bovg-SE0250-Ab-1/ GM-Tg-bovg-SE0250-Ab-2; GM-Tg-equg-SE0250-Ab-1/ GM-Tg-equg-SE0250-Ab-2 |
Products Name | Anti-GUCA2B monoclonal antibody |
Format | mab |
Target Name | GUCA2B |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-GUCA2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0250-Ag-1 | Recombinant multi-species GUC2B/ GUCA2B/ GCAP-II protein |
ORF Viral Vector | pGMLP005002 | human GUCA2B Lentivirus plasmid |
ORF Viral Vector | vGMLP005002 | human GUCA2B Lentivirus particle |
ORF Viral Vector | pGMLPm000973 | mouse Guca2b Lentivirus plasmid |
ORF Viral Vector | vGMLPm000973 | mouse Guca2b Lentivirus particle |
Target information
Target ID | GM-SE0250 |
Target Name | GUCA2B |
Gene ID | 2981,14916,64055,699525,100684829,101092381,515664,100067585 |
Gene Symbol and Synonyms | GCAP-II,Gcap2,GUCA2B,UGN |
Uniprot Accession | Q16661,P70668 |
Uniprot Entry Name | GUC2B_HUMAN,GUC2B_RAT |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | Malignant neoplasm of bladder |
Gene Ensembl | ENSG00000044012 |
Target Classification | N/A |
The target: GUCA2B, gene name: GUCA2B, also named as GCAP-II, UGN. This gene encodes a preproprotein that is proteolytically processed to generate multiple protein products, including uroguanylin, a member of the guanylin family of peptides and an endogenous ligand of the guanylate cyclase-C receptor. Binding of this peptide to its cognate receptor stimulates an increase in cyclic GMP and may regulate salt and water homeostasis in the intestine and kidneys. [provided by RefSeq, Nov 2015].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.